| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/10/04 | 06 : 04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/24 | 19 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/24 | 06 : 10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/24 | 06 : 06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/14 | 06 : 19 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/27 | 23 : 03 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/17 | 06 : 02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/15 | 06 : 12 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/15 | 05 : 16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/23 | 22 : 59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/23 | 22 : 58 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/23 | 06 : 21 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/19 | 03 : 12 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/18 | 06 : 27 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/17 | 05 : 01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/13 | 06 : 24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/12 | 06 : 30 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/12 | 06 : 28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/11 | 06 : 21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/11 | 06 : 19 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/09 | 06 : 26 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/04 | 05 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/04 | 05 : 05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/03 | 23 : 00 | GlobeNewswire Inc. | Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/03 | 06 : 04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/07 | 23 : 28 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/07 | 19 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/07 | 06 : 16 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/04 | 06 : 22 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/05/23 | 06 : 17 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |